These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 8678514

  • 1. [Administration and dosage of fluorouracil (5-FU) continuous i.v. infusion in patients with non-curative resected/non-resected gastric cancer].
    Yamaguchi A, Isogai M, Hori A, Kawai M, Yamaguchi R, Kubota T, Yamada T, Maeda A.
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):567-72. PubMed ID: 8678514
    [Abstract] [Full Text] [Related]

  • 2. A combination chemotherapy of 5-fluorouracil and cisplatin against advanced gastric cancer.
    Imada T, Sairenji M, Suda T, Yamamoto Y, Amano T, Motohashi H.
    Hepatogastroenterology; 1999 Apr; 46(25):594-600. PubMed ID: 10228867
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S, Labianca R, Barone C, Santoro A, Carnaghi C, Cassano A, Beretta GD, Catalano V, Bertetto O, Barni S, Frontini L, Aitini E, Rota S, Torri V, Floriani I, Italian Group for the Study of Digestive Tract Cancer, Pozzo C, Rimassa L, Mosconi S, Giordani P, Ardizzoia A, Foa P, Rabbi C, Chiara S, Gasparini G, Nardi M, Mansutti M, Arnoldi E, Piazza E, Cortesi E, Pucci F, Silva RR, Sobrero A, Ravaioli A.
    J Natl Cancer Inst; 2007 Apr 18; 99(8):601-7. PubMed ID: 17440161
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Biochemical modulation of 5-FU--effect of low dose CDDP].
    Hirata K, Yamamitsu S, Tsuji A, Shirasaka T, Mukaiya M, Oikawa I, Kimura H, Sasaki K, Denno R.
    Gan To Kagaku Ryoho; 1999 Mar 18; 26(4):467-75. PubMed ID: 10097743
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Postoperative adjuvant chemotherapy using NCS (neocarzinostatin) and 5-FU in the treatment of gastric cancer. First report--A comparison with the 5-year survival rate of patients undergoing combined therapy with MMC and 5-FU].
    Yokomori T, Taniguchi T, Iesato H, Sakata Y, Watanabe T, Kawabe K.
    Gan To Kagaku Ryoho; 1987 Nov 18; 14(11):3064-70. PubMed ID: 2960267
    [Abstract] [Full Text] [Related]

  • 12. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
    Koizumi W, Kurihara M, Hasegawa K, Chonan A, Kubo Y, Maekawa R, Iwasaki R, Sasai T, Fukuyama Y, Ishikawa K, Miyoshi K, Yasutake K, Hayakawa M.
    Oncol Rep; 2004 Sep 18; 12(3):557-61. PubMed ID: 15289837
    [Abstract] [Full Text] [Related]

  • 13. Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer.
    Petrioli R, Sabatino M, Roviello F, Marrelli D, Nastri G, Marsili S, Correale P, Pozzessere D, Messinese S, De Martino A, Tani F, Marzocca G, Lorenzi M, Civitelli S, Tanzini G, Pinto E, Francini G.
    Hepatogastroenterology; 2005 Sep 18; 52(65):1626-30. PubMed ID: 16201130
    [Abstract] [Full Text] [Related]

  • 14. [Chemotherapy with low-dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers].
    Tsuji A, Morita S, Horimi T, Takasaki M, Takahashi I, Shirasaka T.
    Gan To Kagaku Ryoho; 1999 Jun 18; 26(7):933-8. PubMed ID: 10396320
    [Abstract] [Full Text] [Related]

  • 15. [The optimal period for orally administered fluoropyrimidines as an adjuvant chemotherapy for gastric cancer--a pilot study using 5-FU tablets compared with surgical operation alone].
    Fujii M, Sakabe T, Wakabayashi K, Kochi M, Mochizuki F, Kasakura Y, Yamagata M, Noro M, Osawa T, Iwai S.
    Gan To Kagaku Ryoho; 1994 Jul 18; 21(8):1199-208. PubMed ID: 8031162
    [Abstract] [Full Text] [Related]

  • 16. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K, Mochizuki Y, Machida T, Yokoyama S, Sodeyama H, Sode Y, Wakabayashi M, Kawamura N, Miyazaki T.
    Hepatogastroenterology; 1999 Jul 18; 46(26):1238-43. PubMed ID: 10370699
    [Abstract] [Full Text] [Related]

  • 17. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
    Smalley SR, Benedetti JK, Williamson SK, Robertson JM, Estes NC, Maher T, Fisher B, Rich TA, Martenson JA, Kugler JW, Benson AB, Haller DG, Mayer RJ, Atkins JN, Cripps C, Pedersen J, Periman PO, Tanaka MS, Leichman CG, Macdonald JS.
    J Clin Oncol; 2006 Aug 01; 24(22):3542-7. PubMed ID: 16877719
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Kondo K, Kobayashi M, Kojima H, Hirabayashi N, Kataoka M, Araki K, Matsui T, Takiyama W, Miyashita Y, Nakazato H, Nakao A, Sakamoto J.
    Jpn J Clin Oncol; 2005 Jun 01; 35(6):332-7. PubMed ID: 15961435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.